General Information of DTT (ID: TTPJ2SH)

DTT Name N-sulphoglucosamine sulphohydrolase (SGSH) DTT Info
Gene Name SGSH

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
4 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
LYS-SAF302 DMUQWRD Mucopolysaccharidosis 5C56.3 Phase 2/3 [1]
HGT-1410 DMHZ4JI Sanfilippo syndrome 5C56.3Y Phase 2 [2]
ABO-102 DMFJB35 Mucopolysaccharidosis 5C56.3 Phase 1/2 [3]
SOBI003 DMXNTR7 Sanfilippo syndrome 5C56.3Y Phase 1/2 [4]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Clinical pipeline report, company report or official report of Lysogene.
2 ClinicalTrials.gov (NCT01155778) Safety, Tolerability, Ascending Dose and Dose Frequency Study of rhHNS Via an IDDD in MPS IIIA Patients. U.S. National Institutes of Health.
3 Clinical pipeline report, company report or official report of Abeona Therapeutics.
4 Clinical pipeline report, company report or official report of Swedish Orphan Biovitrum.